The Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation
Launched by FAYOUM UNIVERSITY · Jan 1, 2025
Trial Information
Current as of September 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new tool called AI Molar Mind, which aims to help people quit smoking by looking at their dental health. Smoking is a major health issue, and many people find it hard to stop even with existing support. The trial is not yet recruiting participants, but it will focus on adults aged 18 to 65 who smoke at least five cigarettes a day and are motivated to quit. Participants must also have access to a smartphone or computer, but pregnant women, people with serious mental health issues, or those already using other smoking cessation methods won’t be able to join.
If you take part in this study, you will be using the AI Molar Mind tool, which is designed to support your journey to quit smoking by evaluating your dental health. The goal is to provide personalized help that can make quitting easier and more effective. This trial is an exciting opportunity for individuals who want to stop smoking and improve their overall health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18-65 years
- • smoke ≥5 cigarettes per day
- • motivated to quit smoking,
- • have access to a smartphone or computer
- Exclusion Criteria:
- • Pregnant women
- • individuals with severe psychiatric conditions
- • those already using other smoking cessation therapies.
About Fayoum University
Fayoum University, a prominent higher education institution in Egypt, is dedicated to advancing medical research and enhancing healthcare outcomes through innovative clinical trials. With a commitment to academic excellence and community health improvement, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, healthcare professionals, and participants, Fayoum University aims to contribute valuable insights to the medical field and promote evidence-based practices that benefit society at large.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fayoum, Alexandria, Egypt
Patients applied
Trial Officials
Alshaimaa Mohamed, PhD
Principal Investigator
Fayoum University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported